Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care 2016;39:179

Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care 2016;39:179–186

Published:2016-07-12 Issue:8 Volume:39 Page:e129-e130
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Schwartz Stanley S.¹,Epstein Solomon²,Corkey Barbara E.³,Grant Struan F.A.⁴,Gavin James R.⁵,Aguilar Richard B.⁶

Affiliation:

1. Main Line Health System, Wynnewood, PA, and University of Pennsylvania, Philadelphia, PA

2. Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Mount Sinai Hospital, New York, NY

3. Department of Medicine, Boston University School of Medicine, Boston, MA

4. Division of Human Genetics and Center for Applied Genomics, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

5. Emory University School of Medicine, Atlanta, GA

6. Diabetes Nation, Sisters, OR

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/39/8/e129/626754/dci160011.pdf

Reference7 articles.

1. Comment on Schwartz et al. The time is right for a new classification system for diabetes: rationale and implications of the β-cell–centric classification schema. Diabetes Care 2016;39:179–186 (Letter);Kalra;Diabetes Care,2016

2. The time is right for a new classification system for diabetes: rationale and implications of the β-cell–centric classification schema;Schwartz;Diabetes Care,2016

3. The emerging role of adjunctive noninsulin antihyperglycemic therapy in the management of type1 diabetes;Bode;Endocr Pract,2016

4. Endogenous hyperinsulinaemia and exogenous insulin: a common theme between atherosclerosis, increased cancer risk and other morbidities;Holden;Atherosclerosis,2012

5. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control;Chico;Diabetes Care,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic aspects of vildagliptin treatment in patients with newly diagnosed type 2 diabetes mellitus;Medical Herald of the South of Russia;2019-10-11